Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
2,513,372
-
Share change
-
+2,500,660
-
Total reported value
-
$6,633,034
-
Price per share
-
$2.64
-
Number of holders
-
11
-
Value change
-
+$6,628,034
-
Number of buys
-
11
-
Number of sells
-
1
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q3 2019
As of 30 Sep 2019,
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,513,372 shares.
The largest 10 holders included
BVF INC/IL, Senvest Management, LLC, MORGAN STANLEY, ORBIMED ADVISORS LLC, ETF MANAGERS GROUP, LLC, NEXT Financial Group, Inc, VAN ECK ASSOCIATES CORP, WELLS FARGO & COMPANY/MN, UBS Group AG, and Asset Dedication, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.